From drug development and commercialization, to pharmacy distribution, clinical administration and analytics, Coram stands on the leading edge of specialty infusion services for the biotech industry. Coram has more than 25 years experience providing complex injectable and infusible medications to patients with both acute and long-term chronic conditions. Our business model is designed to provide biotech manufacturers with a comprehensive, integrated solution to ensure a product’s success in today’s market.

Coram offers the following capabilities, pre- or post-launch, for new or existing pharmaceutical products:

• Largest nationwide network of company-owned infusion pharmacies
• Integrated network of ambulatory infusion suites
• Sales support from more than 200 infusion product specialists
• Clinical support from a staff of more than 1,000 pharmacists and IV-trained nurses
• In-home clinical research services for Phase I through Phase IV trials
• Product outcomes and market data analysis
• More than 850 insurance contracts covering more than 75% of the U.S. population
• Medicaid provider status in all 50 states
• Pharmacy licensure to dispense in all 50 states
• Flexible distribution model – centralized and/or local
• Flexible drug administration support – IV home nurse, infusion suite or self-infusion
• Medical and pharmacy benefit billing
• Specialized clinical protocols and therapy management programs
• Dedicated clinical, marketing and product management support

With hundreds of injectable and infusible drugs in the biotech pipeline, manufacturers are increasingly aware of the need for an experienced partner with far-reaching, flexible pharmacy and infusion services. Coram is ready to deliver.

To learn more about Coram, contact us. To enroll or refer a patient to Coram, click here.